TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · major macro event coming up
ANGO

AngioDynamics Inc

Healthcare · Medical Instruments & Supplies

11.70$ -0.3% vs. previous close Closing price · As of: Nov 3, 2026

Investor relations

Report Dates

Investor relations overview for AngioDynamics Inc (ANGO): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/08/2026.

Next report 10/08/2026
Last report 10/08/2026
Earnings surprise by quarter (%)
Q4 23 · 28.6 % 23 Q1 24 · -6.7 % 24 Q2 24 · 64.7 % 24 Q3 24 · 26.7 % 24 Q4 24 · 63.6 % 24 Q1 25 · 123.1 % 25 Q2 25 · 75.0 % 25 Q3 25 · 16.7 % 25 Q4 25 · -52.9 % 25 Q1 26 · 118.2 % 26 Q2 26 · 36.4 % 26 Q3 26 · 60.0 % 26

EPS estimate beaten

Full history 55 of 90 quarters (61%)
Last 16 quarters 12 of 16 quarters (75%)

Earnings Call Transcripts

Search all transcripts →

  • 10/08/2026 Earnings Call Q3 2026 Open →
  • 07/14/2026 Earnings Call Q2 2026 Open →
  • 04/02/2026 Earnings Call Q1 2026 Open →
  • 01/06/2026 Earnings Call Q4 2025 Open →
  • 10/02/2025 Earnings Call Q3 2025 Open →
  • 07/15/2025 Earnings Call Q2 2025 Open →
  • 04/02/2025 Earnings Call Q1 2025 Open →
  • 01/08/2025 Earnings Call Q4 2024 Open →
  • 10/03/2024 Earnings Call Q3 2024 Open →
  • 07/16/2024 Earnings Call Q2 2024 Open →

News on This Stock

  • 10/08/2026 ANGIODYNAMICS INC (ANGO): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 10/08/2026 ANGIODYNAMICS INC (ANGO): Entry into a Material Definitive Agreement; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/14/2026 ANGIODYNAMICS INC (ANGO): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?